Abstract
Magnetic dynamics of iron oxyhydroxide akaganéite nanoparticles, functional building blocks of the newest generation iron deficiency drug Ferinject, has been studied. While magnetism of the involved nanoparticles relies in general on bulk properties of akaganéite, the low temperature magnetic dynamics of Ferinject differs a lot from large number of other iron-oxides-based intravenous drugs in pharmaceutical practice. Clear separation of the high-temperature (Curie) and the low-temperature (spin-freezing) regimes has been identified. Instead of standard single superparamagnetic blocking temperature we show that the spin freezing relies on the two dominant and superimposed relaxations, characterizing the temperature ranges 50–100 K and 4.2–10 K, respectively. Complex magnetic dynamics is interpreted to rely on presence of the two assemblies of nanoparticles differing significantly in their average sizes. Bimodal distribution of particle sizes has been confirmed using atomic force microscopy. The knowledge of the drug’s physicochemical characteristics has been thus significantly improved.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.